Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 December
OnKure Therapeutics, Inc. has filed 399 SEC EDGAR filings since 08 Jan 2018

SEC filing history

Showing 351-375 of 399 matching filings.

Per page
25
Current page
15
4

FORM 4 SUBMISSION

Filing date
15 Apr 2021
Reporting date
13 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Apr 2021
Reporting date
13 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A SUBMISSION

Filing date
15 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Apr 2021
Reporting date
13 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Apr 2021
Reporting date
13 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-92480

SC 13D

Filing date
14 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Apr 2021
Reporting date
09 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40315

8-K

Filing date
13 Apr 2021
Reporting date
13 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-254534

424B4

Filing date
09 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-255140

S-8

Filing date
09 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
08 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-254534

EFFECT filing

Filing date
08 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
08 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
08 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
08 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
08 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
08 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
08 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .